What does federal net operating loss carryforward mean?

The total amount of historical operating losses that can be applied to offset future taxable income at the federal level. This represents a significant potential tax shield for future profitable periods.

Citius Oncology, Inc. CTOR Federal Net Operating Loss Carryforward

Federal Net Operating Loss Carryforward at other companies

KORU Medical SystemsKRMD

$22.51M+22.9%

Alto Ingredients, Inc.ALTO

$128.8M0.0%

American Coastal Insurance CorporationACIC

$500—

Opus GeneticsIRD

$0—

American Coastal Insurance CorporationACIC

$1.69M—

International Flavors & FragrancesIFF

$334M+25.1%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:FederalNetOperatingLossCarryforward.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s federal net operating loss carryforward.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s federal net operating loss carryforward?: Citius Oncology, Inc. (CTOR) reported federal net operating loss carryforward of $11.79M in Q3 2025.
What does federal net operating loss carryforward mean?: The total amount of historical operating losses that can be applied to offset future taxable income at the federal level. This represents a significant potential tax shield for future profitable periods.